Drug Profile
Lamivudine/zidovudine - Aurobindo Pharma
Alternative Names: Zidovudine/lamivudine tablets - Aurobindo PharmaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Aurobindo Pharma
- Class Antiretrovirals; Azides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV-1 infections
Most Recent Events
- 23 Nov 2018 Drug lamivudine/zidovudine is not yet available in USA for HIV-1 infections (Aurobindo Pharma website, November 2018)